Status:
COMPLETED
Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam
Lead Sponsor:
UCB Pharma
Conditions:
Epilepsy
Eligibility:
All Genders
16+ years
Brief Summary
Phase IV, observational, post-authorization, cross sectional, open-label, multicenter study to evaluate the acceptability of oral solution of levetiracetam in patients with partial epilepsy as assesse...
Eligibility Criteria
Inclusion
- Patients 16 years old or older diagnosed with partial epilepsy with or without generalization receiving levetiracetam oral solution for at least 28 days before the study
Exclusion
- Patients with disturbances of the sense of taste and smell that can interfere with the assessment of the parameters of the study
Key Trial Info
Start Date :
April 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2006
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00319605
Start Date
April 1 2006
End Date
July 1 2006
Last Update
May 25 2012
Active Locations (54)
Enter a location and click search to find clinical trials sorted by distance.
1
A Coruña, Spain
2
Alcalá de Henares, Spain
3
Alcázar de San Juan, Spain
4
Alcorcón, Spain